Insider · CIK 0001289884

Ketchum Steven B

Reports to the SEC for 3 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001289884

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-01	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+3,688 sh	—	—	44,567
2026-07-01	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−1,887 sh	$15.94	−$30.1K	42,680
2026-07-01	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitA Award	EVP, Chief Scientific Officer	AAward	+3,688 sh	—	—	0
2026-02-01	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitA Award	EVP, Chief Scientific Officer	AAward	+8,013 sh	—	—	8,013
2026-02-01	AMRNAMARIN CORP PLC\UK · Stock Option (right to buy)A Award	EVP, Chief Scientific Officer	AAward	+36.1K sh	—	—	36,060
2026-01-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+2,246 sh	—	—	41,243
2026-01-31	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−1,235 sh	$15.42	−$19K	40,008
2026-01-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+1,933 sh	—	—	41,941
2026-01-31	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−1,062 sh	$15.42	−$16.4K	40,879
2026-01-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+2,246 sh	—	—	0
2026-01-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+1,933 sh	—	—	1,933
2026-01-02	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+3,688 sh	—	—	41,038
2026-01-02	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−2,041 sh	$13.96	−$28.5K	38,997
2026-01-02	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitA Award	EVP, Chief Scientific Officer	AAward	+3,688 sh	—	—	3,688
2025-01-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+34.6K sh	—	—	728,524
2025-01-31	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−19.2K sh	$0.62	−$11.9K	709,327
2025-01-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+44.9K sh	—	—	754,260
2025-01-31	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−24.8K sh	$0.62	−$15.4K	729,427
2025-01-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+38.7K sh	—	—	768,094
2025-01-31	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−21.1K sh	$0.62	−$13.1K	747,001
2025-01-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+34.6K sh	—	—	0
2025-01-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+44.9K sh	—	—	44,934
2025-01-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+38.7K sh	—	—	77,333
2025-01-30	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+51.5K sh	—	—	722,340
2025-01-30	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−28.4K sh	$0.62	−$17.6K	693,958
2025-01-30	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitA Award	EVP, Chief Scientific Officer	AAward	+51.5K sh	—	—	0
2025-01-30	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−51.5K sh	—	—	0
2025-01-10	AMRNAMARIN CORP PLC\UK · Stock Option (right to buy)A Award	EVP, Chief Scientific Officer	AAward	+664K sh	—	—	663,878
2024-07-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+23.9K sh	—	—	682,603
2024-07-31	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−11.8K sh	$0.78	−$9,175.14	670,840
2024-02-01	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitA Award	EVP, Chief Scientific Officer	AAward	+116K sh	—	—	116,000
2024-02-01	AMRNAMARIN CORP PLC\UK · Stock Option (right to buy)A Award	EVP, Chief Scientific Officer	AAward	+418K sh	—	—	418,000
2024-01-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+34.6K sh	—	—	654,974
2024-01-31	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−18.9K sh	$1.24	−$23.4K	636,103
2024-01-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+44.9K sh	—	—	681,036
2024-01-31	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−22.3K sh	$1.24	−$27.7K	658,720
2024-01-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−34.6K sh	—	—	34,566
2024-01-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−44.9K sh	—	—	89,867
2024-01-10	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+51.5K sh	—	—	648,677
2024-01-10	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−28.3K sh	$0.97	−$27.4K	620,407
2024-01-10	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitA Award	EVP, Chief Scientific Officer	AAward	+51.5K sh	—	—	0
2024-01-10	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−51.5K sh	—	—	0
2024-01-04	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+14.6K sh	—	—	604,907
2024-01-04	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	−7,730 sh	$0.87	−$6,725.1	597,177
2024-01-04	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	−14.6K sh	—	—	0
2023-12-29	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+47.8K sh	—	—	613,866
2023-12-29	AMRNAMARIN CORP PLC\UKF Tax Payment	EVP, Chief Scientific Officer	FTax Payment	+23.5K sh	$0.87	+$20.5K	590,341
2023-12-29	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+47.8K sh	—	—	47,766
2023-12-12	AMRNAMARIN CORP PLC\UKS Sale	EVP, Chief Scientific Officer	SSale	−34.1K sh	$0.79	−$27K	566,100
2023-07-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Scientific Officer	MExercise/Conversion	+23.9K sh	—	—	0

Recent filings

Accepted (ET)
Jul 154
Ketchum Steven B0001193125-26-304911
SEC(opens sec.gov)
Feb 34
Ketchum Steven B0001193125-26-036169
SEC(opens sec.gov)
Jan 64
Ketchum Steven B0001193125-26-004718
SEC(opens sec.gov)
Jan 314
Ketchum Steven B0000950170-25-011824
SEC(opens sec.gov)

Companies

Address

C/O AMARIN PHARMA, INC. 440 US HIGHWAY 22

BRIDGEWATER, NJ, 08807